Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection

Chinese Medical Journal

Volumn 116, Issue 6, 2003, Pages 913-917

  Zhang, Bin ^a   Zong, Yongsheng ^a   He, Jiehua ^a   Zhong, Biling ^a   Lin, Suxia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Immunophenotype; Lymphoma; Nasopharynx; Non Hodgkin

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD79ALPHA ANTIGEN; CD8 ANTIGEN; CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2A; LYMPHOCYTE ANTIGEN; MEMBRANE ANTIGEN; SMALL NUCLEAR RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NASOPHARYNX CANCER; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PREVALENCE; SCHOOL CHILD; T CELL LYMPHOMA; TUMOR BIOPSY; VIRUS INFECTION; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RNA, VIRAL;

EID: 0037560061     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 1992;69:3-7.
2. Zong YS, Liu KL, Zhong BL, et al. Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou. Chin Med J 2001;114:132-136.
3. Chiang AK, Tao Q, Srivastava G, et al. Nasal NK- and T cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996;68:285-290.
4. Harris NL, Jaffe ES, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoitic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
5. Chan JKC. The new world health organization classification of lymphomas: the past, the present and the future. Hematological Oncology 2001 ;19:129-150.
6. Cotran RS, Kumar V, Collins T. Robbins pathologic basis of disease, 6th ed. W B Sanders Company: New York; 1999: 652-653.
7. Kinney MC. The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T cell or NK cell neoplasms. Am J Clin Pathol 1999; 111 :S104-S118.
8. Lei KI, Suen JJ, Hui P, et al. SH. Primary nasal and nasopharyngeal lymphomas: a comparative study of clinical presentation and treatment outcome. Clin Oncol (R Coll Radiol) 1999;11:379-387.
9. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-77.
10. Hoederath A, Sack H, Stuschke M. Radiotherapy of primary extranodal non-Hodgkin' s lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies. Strahlenther Onkol 1996; 172: 356-366.
11. Ye YL, Zhou MH, Lu XY, et al. Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology 1992;20:511-516.
12. Gao ZF, Wang HH, Pan ZG, et al. Investigation of the clinicopathologic features, immunophenotype and Epstein-Barr virus infection of upper respiratory tract lymphomas in patients (in Chinese). Chin J Pathol 1998;27:251-254.
13. Hahn JS, Lee ST, Min YH, et al. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract. Yonsei Med J 2002;43:175-182.
14. Chinen K, Kaneko Y, Izumo T, et al. Nasal natural killer cell/ T cell lymphoma showing cellular morphology mimicking normal lymphocytes. Arch Pathol Lab Med 2002;126:602-605.
15. Sugimoto T, Hashimoto H, Enjoji M. Nasopharyngeal carcinomas and malignant lymphomas: an immunohisto-chemical analysis of 74 cases. Laryngoscope 1990;100:742-748.
16. Norval EJ, Thompson IO. Non-Hodgkin's lymphomas of Waldeyer's ring: a clinicopathological and immunological study of 64 cases in the western Cape. SADJ 2001;56:545-548.
17. + non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resisteance. Blood 1997;89:2966-2974.
18. + phenotype. Rinsho Ketsueki 1995;36:12-17.
19. Kluin PM, Feller A, Gaulard P, et al. Peripheral T/NK cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001;38: 250-70.
20. Rudiger T, Weisenburger DD, Anderson JR, et al. Non-Hodgkin's Lymphoma. Classification Project. Peripheral T cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13:140-149.
21. Ohshima K, Liu Q, Koga T, et al. Classification of cell lineage and anatomical site, and prognosis of extranodal T cell lymphoma - natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch 2002;440:425-435.
22. Ng CS, Chan JK and Lo ST. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18:1257-1262.
23. Tomita Y, Aozasa K. Epstein-Barr virus and malignant lymphoma. Nippon Rinsho 2000;58:548-553.
24. Matanos, Nakamura S, Nakamura S, et al. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association. Acta Haemetol 1999; 101: 206-208.
25. Chan JK, Sin VC, Wong KF, et al. Normasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.